Lupin informs about press release

14 Nov 2025 Evaluate
Lupin has informed that it enclosed a Press Release titled ‘Lupin Launches Risperidone Long-Acting Injectable with 180- day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2360.00 19.25 (0.82%)
11-Mar-2026 10:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1822.60
Dr. Reddys Lab 1326.05
Cipla 1327.20
Zydus Lifesciences 930.00
Lupin 2360.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×